Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Mephisto who wrote (1284)	9/24/1999 3:11:00 PM
From: SIer formerly known as Joe B.	Read Replies (2) \| Respond to of 1580

September 24, 1999 Dow Jones Newswires Merck CEO Gilmartin Backs '99 Street EPS Views By Melanie Trottman NEW YORK -- At a time when some drug companies are looking externally to grow, Merck & Co. (MRK) is "absolutely" still ruling out the possibility of a merger, said Raymond Gilmartin, president, chairman and chief executive of the drug giant. Gilmartin ruled out the possibility earlier Friday in a meeting with reports and editors at the Wall Street Journal. He later told Dow Jones Newswires that he was comfortable with Street views for the company's earnings per share in 1999. Analysts surveyed by First Call/Thomson Financial expect the Whitehouse Station, N.J. company to earn $2.45 a share for the year. Gilmartin said the company's strategy is to grow internally.